Doctor profile · Federal record
Dr. Stanley Schinke, M.D.
Specialist (CMS: Hematology) · Hemet, CA
- NPI 1649277088
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 43 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
301 N San Jacinto St
Hemet, CA 925433113
(951) 766-6460
fax (951) 766-6459 - Mailing address
-
42125 Crest Dr
Hemet, CA 925448400
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- February 5, 2009
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- California #G55989
- Medicaid
- CA #00G559890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649277088. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
251,451
Distinct HCPCS
10
Medicare allowed
$3,552,083
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 92,250 | 91 | $1 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 18,360 | 24 | $46 | |
J9025 |
Injection, azacitidine, 1 mg | 18,000 | 11 | $0 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 14,890 | 73 | $7 | |
J9299 |
Injection, nivolumab, 1 mg | 10,780 | 13 | $30 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 10,710 | 15 | $1 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 9,600 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 8,820 | 36 | $21 | |
J9271 |
Injection, pembrolizumab, 1 mg | 8,200 | 18 | $54 | |
J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units | 7,951 | 69 | $0 |
In context: peer comparison
Among 6 peers in Hemet Specialist, average services per provider: 3,170. This provider delivers 79× the peer median.Open Payments
Industry payments received
All-time total
$3,478
Transactions
109
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $469.15 | |
| Merck Sharp & Dohme LLC | 10 | $245.26 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $194.77 | |
| Daiichi Sankyo INC. | 7 | $193.16 | |
| Abbvie INC. | 8 | $188.42 | |
| Janssen Biotech, INC. | 7 | $181.97 | |
| Pfizer INC. | 7 | $172.55 | |
| AstraZeneca Pharmaceuticals Lp | 7 | $167.41 | |
| Eisai INC. | 6 | $137.34 | |
| Takeda Pharmaceuticals U.S.A., INC. | 5 | $129.46 | |
| Astellas Pharma US INC | 5 | $116.35 | |
| Genzyme Corporation | 2 | $80.23 | |
| Array Biopharma INC | 3 | $79.13 | |
| Genentech USA, INC. | 3 | $72.03 | |
| Karyopharm Therapeutics INC. | 3 | $69.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
745
Patients
222
Total drug cost
$1,195,290
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 102 | 33 | $1,948 |
| Ondansetron Hcl | Generic | 97 | 42 | $1,002 |
| Anastrozole | Generic | 78 | 22 | $3,310 |
| Acyclovir | Generic | 63 | 18 | $1,153 |
| Prochlorperazine Maleate | Generic | 56 | 30 | $767 |
| Letrozole | Generic | 50 | 14 | $1,341 |
| Hydroxyurea | Generic | 49 | 15 | $2,813 |
| Prednisone | Generic | 46 | 19 | $281 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 42 | 18 | $1,552 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 33 | 0 | $723 |
Frequently asked questions
What is Dr. Stanley Schinke's medical specialty?
Dr. Stanley Schinke practices Specialist in Hemet, CA.
Where does Dr. Stanley Schinke practice?
Dr. Stanley Schinke practices at 301 N San Jacinto St, Hemet, CA 925433113. Office phone: 9517666460.
What is Dr. Stanley Schinke's NPI?
Dr. Stanley Schinke's National Provider Identifier (NPI) is 1649277088, issued by NPPES.
Does Dr. Stanley Schinke accept Medicare assignment?
Yes. Dr. Stanley Schinke accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stanley Schinke commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, azacitidine, 1 mg (HCPCS J9025). Source: CMS Medicare Physician & Other Practitioners file.